What is Altimmune's AOCI?

Altimmune (ALT) reported AOCI of -$5.22M in Q1 2026.

How has Altimmune's AOCI changed year-over-year?

Altimmune's AOCI decreased by 4.4% year-over-year, from -$5M to -$5.22M.

What is the long-term trend for Altimmune's AOCI?

Over 5 years (2020 to 2025), Altimmune's AOCI has grown at a -0.5% compound annual growth rate (CAGR), from -$5.04M to -$4.93M.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

Altimmune ALT AOCI

AOCI at other companies

Eli LillyLLY

-$2.83B+24.9%

Merck & Co.MRK

-$4.06B+18.2%

Madrigal Pharmaceuticals, Inc.MDGL

$1.08M+178%

Viking TherapeuticsVKTX

-$856K-296%

Wave Life SciencesWVE

-$254K-24.5%

Delcath SystemsDCTH

$571K+49.9%

Other financials

Income statement

See full

Revenue$26.0K+420%

Operating income-$24.2M-11.1%

Net income-$22.6M-15.3%

EPS (diluted)-$0.18+30.8%

Balance sheet

See full

Cash & equivalents$97.6M+98.7%

Total debt$34.8M+14,092%

Total equity$284.0M+99.8%

Total assets$335.6M+113%

Cash flow

See full

Operating cash flow-$20.9M-24.4%

CapEx$21.0K—

Free cash flow-$21.0M—

Valuation

See full

Market cap$558.14M-2.1%

Enterprise value$495.27M-5.0%

P/S13,613.2×-24,380×

Profitability

See full

Operating margin-230,461%-82,087pp

Net margin-214,861%-76,057pp

FCF margin-17,806.8%-110,030pp

Returns & leverage

See full

Return on equity-42.7%-8.7pp

Debt / equity0.1×+0.1×

Current ratio29.6×+13.7×

Where this comes from

Reported directly by Altimmune in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: Altimmune’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Altimmune's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Altimmune's AOCI?: Altimmune (ALT) reported AOCI of -$5.22M in Q1 2026.
How has Altimmune's AOCI changed year-over-year?: Altimmune's AOCI decreased by 4.4% year-over-year, from -$5M to -$5.22M.
What is the long-term trend for Altimmune's AOCI?: Over 5 years (2020 to 2025), Altimmune's AOCI has grown at a -0.5% compound annual growth rate (CAGR), from -$5.04M to -$4.93M.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.